Dr. Ruben Gonzalez's lab at Columbia University focuses on understanding how the ribosome, a vital cellular structure, translates messenger RNA (mRNA) into proteins. The research explores the structural dynamics and control mechanisms of translation in both bacteria and humans, aiming to uncover new ways to combat diseases linked to translation processes. The lab employs advanced techniques like single-molecule fluorescence and structural biology to study these intricate systems, with the hope of aiding in the development of novel antibiotics and therapeutics.

The lab led by Dr. Dalibor Sames at Columbia University focuses on researching iboga alkaloids, particularly ibogaine, which is known for its potential to treat substance use disorders like addiction to opioids and alcohol. The lab is developing safer analogs of ibogaine that maintain therapeutic benefits while minimizing cardiac risks. They also investigate the pharmacological properties of these new compounds in various disease models, aiming to pave the way for innovative treatments for substance addiction and related mental health issues.

Dr. Tomislav Rovis' lab focuses on innovative methods to transform basic chemical feedstocks into valuable compounds, especially those containing nitrogen, which is crucial for drug development. By synthesizing complex structures from simple molecules, the lab aims to streamline the creation of pharmaceutical agents and improve their properties. This research has a significant impact on drug design and functionality, addressing challenges in the development of therapeutics.

Dr. Virginia W. Cornish's lab at Columbia University focuses on developing innovative therapeutic approaches using engineered yeast. They are creating living yeast cells that can act as biosensors to detect infections and secrete antibiotics directly where needed, like in wound care. This research aims to improve treatment strategies for various diseases by utilizing synthetic biology techniques to manipulate yeast at the genome level.

Dr. Wei Min's lab at Columbia University focuses on developing innovative imaging technologies to study complex biological systems. They aim to break existing limitations in optical imaging by creating new tools that can simultaneously observe many different biological components with high precision and resolution. This research is crucial for understanding how various cells and tissues interact in living organisms, ultimately contributing to advancements in disease diagnosis and biology.